Status:
RECRUITING
Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate
Lead Sponsor:
Smita De
Conditions:
BPH With Symptomatic Lower Urinary Tract Symptoms
BPH With Urinary Obstruction
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Many consider laser enucleation of the prostate the new 'gold standard' for the surgical treatment of benign prostatic hyperplasia (BPH) due to its excellent outcomes, high success rates, and long-ter...
Detailed Description
Study Design This is a prospective randomized study to evaluate the differences in outcomes comparing the existing laser to a new laser among patients undergoing HoLEP. Patients will be evaluated prio...
Eligibility Criteria
Inclusion
- Understand and voluntarily sign an informed consent form.
- Patients must be males with a prostate, at least 18 years of age
- No prior prostate surgery
Exclusion
- Unable/refuse to provide informed consent
- Prior prostate surgery
- Bladder stones that requiring lasering (small stone that can be removed whole is ok)
- Unable to hold anticoagulants or antiplatelets per standard protocols for surgery and up to 1 week postop.
Key Trial Info
Start Date :
June 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07187180
Start Date
June 2 2025
End Date
September 1 2026
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Main
Cleveland, Ohio, United States, 44195